Ozempic

The survey included 2,205 adults and was conducted on September 5, 2024

The market for oral GLP-1RAs is expanding, and Rybelsus’ latest results showed its benefits in reducing the risk in cardiovascular…

Regulator highlights risks of dosing errors and adverse events, urges healthcare providers to ensure correct syringe use and…

The study, published in the Lancet's eClinicalMedicine journal, explored more than 100 million medical records of the U.S.…

The warnings were issued on fake drugs claiming to contain the active ingredient found in Novo Nordisk's diabetes drug Ozempic…

Shift could reflect a changing demand away from oncology toward addressing metabolic disorders

The acquisition of Catalent by Novo Holdings expects to see three new manufacturing sites added to Novo Nordisk’s arsenal, to…

Ozempic demonstrated 2.1 per cent blood sugar reduction and also weight loss in adults with type-II diabetes with new 2 mg dose

The market has been a lucrative space for drug developers, as the disease is highly prevalent and patient numbers are expected to…

T2D market growth factors are increasing diagnosed prevalence of disease and the emergence of novel pipeline agents